https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-702006-01-17 00:00:002019-02-15 09:19:51Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-432006-01-09 00:00:002019-02-15 09:15:17Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-05 / Breast Cancer Res. 2006;8(1):101
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-05 / Breast Cancer Res. 2006;8(1):1012006-01-05 00:00:002019-02-15 08:44:41Dendritic cell defects in patients with cancer: mechanisms and significance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Tohoku J. Exp. Med. 2006 Jan;208(1):1-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Tohoku J. Exp. Med. 2006 Jan;208(1):1-82006-01-01 00:00:002019-02-15 08:44:43Genetically modified dendritic cells for therapeutic immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Cytotherapy 2006;8(4):318-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Cytotherapy 2006;8(4):318-262006-01-01 00:00:002019-02-15 08:45:56Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Clin Neurosurg 2006;53:345-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Clin Neurosurg 2006;53:345-512006-01-01 00:00:002019-02-15 08:59:51Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Cytotherapy 2006;8(6):580-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Cytotherapy 2006;8(6):580-82006-01-01 00:00:002019-02-15 09:03:05Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Immunol. Res. 2006;36(1-3):265-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Immunol. Res. 2006;36(1-3):265-742006-01-01 00:00:002019-02-15 09:15:12Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / J Gene Med 2006 Jan;8(1):3-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / J Gene Med 2006 Jan;8(1):3-172006-01-01 00:00:002019-02-15 09:15:18From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Adv. Immunol. 2006;90:243-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Adv. Immunol. 2006;90:243-952006-01-01 00:00:002019-02-15 09:19:49Immunity to melanoma antigens: from self-tolerance to immunotherapy
